The people behind Helix
We’re a rapidly growing company working out of the Bay Area, Denver, and San Diego.
Scientific Advisory Board
Our advisory board is comprised of the world’s foremost experts in genomics. Each member serves an important role in upholding our high scientific standards and serves as a strategic resource as we build an ongoing destination for DNA discovery.
Chief Financial Officer
VP, Data Science in Engineering
Robert Green, MD, MPH
Robert Green, MD, MPH is Chairman of the Helix Scientific Advisory Board. He is also Professor of Medicine and Director of the Genomes2People Research Program at Brigham and Women’s Hospital and Harvard Medical School, and an associate member of the Broad Institute. Dr. Green’s research focuses upon randomized trials and observational studies to assess the medical, behavioral and economic outcomes of using genomics in medicine and society.
Nita Farahany, JD, PhD
Nita Farahany, JD, PhD is Professor of Law and Philosophy, Director of Duke Science & Society at Duke University, and a member of the Presidential Commission for the Study of Bioethics. Her research focuses on how developments in behavioral genetics and neuroscience inform societal norms about privacy and individual liberty.
Goncalo Abecasis, PhD
Goncalo Abecasis, PhD, is Felix E. Moore Collegiate Professor of Biostatistics and Chair of the Department of Biostatistics at the University of Michigan. Dr. Abecasis’ research focuses on the development of statistical tools for the identification and study of genetic variants important in human disease.
Judy Garber, MD, MPH
Judy Garber, MD, MPH is Professor of Medicine at Harvard Medical School and Director, Center for Cancer Genetics and Prevention at Dana Farber Cancer Institute. Dr. Garber’s recent research has evaluated novel agents targeting DNA repair defects in treatment and prevention of triple-negative or basal-like breast cancer.
Atul Butte, MD, PhD
Atul Butte, MD, PhD is Professor of Pediatrics and Director of the Institute of Computational Health Sciences (ICHS) at the University of California, San Francisco. Dr. Butte’s laboratory builds and applies tools that integrate molecular, clinical, and epidemiological data into diagnostics, therapeutics, and new insights into disease.
Keith Stewart, MB, CHB
Keith Stewart, MB, CHB is the Carlson and Nelson Endowed Director, Mayo Clinic Center for Individualized Medicine and the Vasek and Anna Maria Polak Professor of Cancer Research. Dr. Stewart is responsible for systematically introducing clinical genomics to routine medical practice at Mayo Clinic incorporating prevention, diagnosis and treatment across the spectrum of medical specialties.